Faeth Therapeutics, Inc.

FTH

$24.59

Today

as of Aug 5, 16:49 ET

Last 30 days +5.90% Jun 29 → Aug 05

Open

—

High

—

Low

—

Volume

—

Avg Vol

—

Mkt Cap

$702M

P/E (TTM)

—

Beta

—

52w High

—

52w Low

—

Div Yield

—

Shares Out

—

Recent Press Releases & News last 60 days · 6 items

Aug 4 · 11:30 PR Business Wire

Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates

Jul 31 · 11:10 MT Newswires

Raymond James Initiates Faeth Therapeutics at Outperform

Jul 28 · 15:34 MT Newswires

Faeth Therapeutics' Experimental Cancer Drug Piktor Has Upside Potential, Oppenheimer Says

▸ Show all 6 press releases & news Free account →

Overview

52-week range

—

Avg surprise (last 1)

+36.9%

Avg reaction (last 0)

—

Earnings trends

EPS — actual vs estimate Actual Estimate

Earnings history

Date	Period	Actual EPS	Est	Surprise	YoY %Δ	Day react	Source
Tue Aug 5, 2025	Jun/2025	$-3.91	$-6.20	+36.9%	—	—	earnings

Implied volatility — last 90 days

No IV snapshots yet for FTH.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

View on Nasdaq ↗